Terazosin hydrochloride

• Description:

  Terazosin is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  423.89

• Molecular Formula:

  C19H26ClN5O4

• Notes:

  Research use only, not for human use.

• Receptor:

  Α-adrenergic receptor

• CAS Number:

  63074-08-8